Studies have shown preoperative opioid use to influence outcomes after various surgical procedures. Researchers have not assessed this relationship after rotator cuff repair (RCR).
Hypothesis/Purpose:
The purpose was to assess the relationship between preoperative opioid use and outcomes after arthroscopic RCR. We hypothesized that patients prescribed higher daily averages of preoperative oral morphine equivalents (OMEs) would show increased rates of 90-day complications and 3-year revision surgery.
Study Design:
Cohort study; Level of evidence, 3.
Methods:
The MarketScan claims database was utilized to identify patients who underwent arthroscopic RCR between 2009 and 2018. We used preoperative opioid use status to divide patients into groups based on the average daily OMEs consumed in the 6 months before surgery: opioid-naïve, <1, 1-<5, 5-<10, and ≥10 OMEs per day. We retrieved 90-day complication and 3-year revision surgery rates. Opioid use groups were then compared with binomial logistic regression and generalized linear models.
Results:
We identified 214,283 patients. Of those patients, 50.7% did not receive any preoperative opioids, while 7.7%, 26.8%, 6.3%, and 8.6% received <1, 1-<5, 5-<10, and ≥10 OMEs per day over a 6-month time period, respectively. Complications increased with increasing preoperative OMEs. Multivariate analysis revealed that any patient using ≥1 OME per day had increased rates of 3-year revision surgery, reoperations, and infections. Specifically, patients averaging ≥10 OMEs per day showed a 103% (odds ratio, 2.03 [95% CI, 1.62-2.54]; P < .001) increase in the odds of revision surgery compared with opioid-naïve patients. Rates of hospital admissions and postoperative emergency department encounters were higher in all opioid use groups. Adjusted differences in 6-month preoperative and 3-month postoperative health care costs were seen in the opioid use groups compared with opioid-naïve patients, ranging from US$1307 to US$5820 (P < .001).
Conclusion:
Preoperative opioid use was a risk factor for complications and revision surgery after arthroscopic RCR. We also observed a dose-dependent response between opioid use and postoperative complications.
AasvangEKLunnTHHansenTB, et al. Chronic pre-operative opioid use and acute pain after fast-track total knee arthroplasty. Acta Anaesthesiol Scand. 2016;60(4):529-536.
2.
AgarwalSBryanJDHuHM, et al. Association of state opioid duration limits with postoperative opioid prescribing. JAMA Netw Open. 2019;2(12):e1918361.
3.
AizpuruMGalloLKFarleyKX, et al. Economic burden and clinical impact of preoperative opioid dependence for patients undergoing lower extremity bypass surgery. J Vasc Surg. 2020;71(5):1613-1619.
4.
AnastasioATFarleyKXBodenSD, et al. Modifiable, postoperative risk factors for delayed discharge following total knee arthroplasty: the influence of hypotension and opioid use. J Arthroplasty. 2020;35(1):82-88.
5.
AteschrangAEggenspergerFAhrendMD, et al. Obesity causes poorer clinical results and higher re-tear rates in rotator cuff repair. Arch Orthop Trauma Surg. 2018;138(6):835-842.
6.
BedardNADeMikDEDowdleSB, et al. Does preoperative opioid use increase the risk of early revision total hip arthroplasty?J Arthroplasty. 2018;33(7)(suppl):S154-S156.
7.
BedardNADeMikDEDowdleSB, et al. Preoperative opioid use and its association with early revision of total knee arthroplasty. J Arthroplasty. 2018;33(11):3520-3523.
8.
BedardNAPugelyAJDowdleSB, et al. Opioid use following total hip arthroplasty: trends and risk factors for prolonged use. J Arthroplasty. 2017;32(12):3675-3679.
9.
BedardNAPugelyAJWestermannRW, et al. Opioid use after total knee arthroplasty: trends and risk factors for prolonged use. J Arthroplasty. 2017;32(8):2390-2394.
10.
BellKLShohatNGoswamiK, et al. Preoperative opioids increase the risk of periprosthetic joint infection after total joint arthroplasty. J Arthroplasty. 2018;33(10):3246-3251.e1.
11.
Blevins PeratikosMWeeksHLPisanskyAJBYongRJStringerEA.Effect of preoperative opioid use on adverse outcomes, medical spending, and persistent opioid use following elective total joint arthroplasty in the United States: a large retrospective cohort study of administrative claims data. Pain Med. 2020;21(3):521-531.
12.
BonnerBECastilloTNFitzDW, et al. Preoperative opioid use negatively affects patient-reported outcomes after primary total hip arthroplasty. J Am Acad Orthop Surg. 2019;27(22):e1016-e1020.
13.
CancienneJMPatelKJBrowneJAWernerBC.Narcotic use and total knee arthroplasty. J Arthroplasty. 2018;33(1):113-118.
14.
ClarkeHSonejiNKoDTYunLWijeysunderaDN.Rates and risk factors for prolonged opioid use after major surgery: population based cohort study. BMJ. 2014;348:G1251.
15.
ColvinACEgorovaNHarrisonAKMoskowitzAFlatowEL.National trends in rotator cuff repair. J Bone Joint Surg Am. 2012;94(3):227-233.
16.
CozowiczCOlsonAPoeranJ, et al. Opioid prescription levels and postoperative outcomes in orthopedic surgery. Pain. 2017;158(12):2422-2430.
17.
DahlhamerJLucasJZelayaC, et al. Prevalence of chronic pain and high-impact chronic pain among adults: United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(36):1001-1006.
18.
DowellDHaegerichTMChouR.CDC guideline for prescribing opioids for chronic pain: United States, 2016. MMWR Recomm Rep. 2016;65(1):1-49.
FarleyKXAnastasioATPremkumarA, et al. The influence of modifiable, postoperative patient variables on the length of stay after total hip arthroplasty. J Arthroplasty. 2019;34(5):901-906.
21.
ForsytheBAgarwallaAPuzzitielloRN, et al. The timing of injections prior to arthroscopic rotator cuff repair impacts the risk of surgical site infection. J Bone Joint Surg Am. 2019;101(8):682-687.
22.
FranklinPDKarbassiJALiWYangWAyersDC.Reduction in narcotic use after primary total knee arthroplasty and association with patient pain relief and satisfaction. J Arthroplasty. 2010;25(6)(suppl):12-16.
23.
HouryDBaldwinG.Announcing the CDC guideline for prescribing opioids for chronic pain. J Safety Res. 2016;57:83-84.
24.
JacobsCAHawkGSJochimsenKN, et al. Depression and anxiety are associated with increased health care costs and opioid use for patients with femoroacetabular impingement undergoing hip arthroscopy: analysis of a claims database. Arthroscopy. 2020;36(3):745-750.
25.
JainNBrockJLMalikATPhillipsFMKhanSN.Prediction of complications, readmission, and revision surgery based on duration of preoperative opioid use: analysis of major joint replacement and lumbar fusion. J Bone Joint Surg Am. 2019;101(5):384-391.
26.
JainNBHigginsLDLosinaE, et al. Epidemiology of musculoskeletal upper extremity ambulatory surgery in the United States. BMC Musculoskelet Disord. 2014;15:4.
27.
JensenARChaPSDevanaSK, et al. Evaluation of the trends, concomitant procedures, and complications with open and arthroscopic rotator cuff repairs in the Medicare population. Orthop J Sports Med. 2017;5(10):2325967117731310.
28.
JohnsonSPChungKCZhongL, et al. Risk of prolonged opioid use among opioid-naive patients following common hand surgery procedures. J Hand Surg Am. 2016;41(10):947-957.e3.
29.
KosinskiLRGilJADurandWM, et al. 30-day readmission following outpatient rotator cuff repair: an analysis of 18,061 cases. Phys Sportsmed. 2018;46(4):466-470.
30.
MackiMAlviMAKerezoudisP, et al. Predictors of patient dissatisfaction at 1 and 2 years after lumbar surgery. J Neurosurg Spine. Published online November22, 2019. doi: 10.3171/2019.8.SPINE 19260
31.
ManaloJPMCastilloTHennessyD, et al. Preoperative opioid medication use negatively affect health related quality of life after total knee arthroplasty. Knee. 2018;25(5):946-951.
32.
MorrisBJLaughlinMSElkousyHAGartsmanGMEdwardsTB.Preoperative opioid use and outcomes after reverse shoulder arthroplasty. J Shoulder Elbow Surg. 2015;24(1):11-16.
33.
MorrisBJSciasciaADJacobsCAEdwardsTB.Preoperative opioid use associated with worse outcomes after anatomic shoulder arthroplasty. J Shoulder Elbow Surg. 2016;25(4):619-623.
34.
NadarajahVStevensKNHenryL, et al. Patients undergoing shoulder surgery have high preoperative expectations. Knee Surg Sports Traumatol Arthrosc. 2020;28(7):2377-2385.
35.
NicholsonADKassamHFSteeleJL, et al. Development of a clinical risk calculator for prolonged opioid use after shoulder surgery. J Shoulder Elbow Surg. 2019;28(11):2225-2231.
36.
OldsCSpataroELiKKandathilCMostSP.Assessment of persistent and prolonged postoperative opioid use among patients undergoing plastic and reconstructive surgery. JAMA Facial Plast Surg. 2019;21(4):286-291.
OwensBDWilliamsAEWolfJM.Risk factors for surgical complications in rotator cuff repair in a veteran population. J Shoulder Elbow Surg. 2015;24(11):1707-1712.
39.
PleinLMRittnerHL.Opioids and the immune system: friend or foe. Br J Pharmacol. 2018;175(14):2717-2725.
40.
PugelyAJBedardNAKalakotiP, et al. Opioid use following cervical spine surgery: trends and factors associated with long-term use. Spine J. 2018;18(11):1974-1981.
41.
RaoAGChanPHPrenticeHA, et al. Risk factors for opioid use after anterior cruciate ligament reconstruction. Am J Sports Med. 2019;47(9):2130-2137.
42.
RashidMSCooperCCookJ, et al. Increasing age and tear size reduce rotator cuff repair healing rate at 1 year. Acta Orthop. 2017;88(6):606-611.
43.
ReidDBCShahKNShapiroBH, et al. Mandatory prescription limits and opioid utilization following orthopaedic surgery. J Bone Joint Surg Am. 2019;101(10):e43.
44.
RosenthalBDSuleimanLIKannanA, et al. Risk factors for prolonged postoperative opioid use after spine surgery: a review of dispensation trends from a state-run prescription monitoring program. J Am Acad Orthop Surg. 2019;27(1):32-38.
45.
SabesanVJPetersen-FittsGRSweetMC, et al. The impact of preoperative opioid use on outcomes after arthroscopic rotator cuff repair. JSES Open Access. 2018;2(3):155-158.
46.
SchairerWWNwachukwuBUFuMCWarrenRF.Risk factors for short-term complications after rotator cuff repair in the United States. Arthroscopy. 2018;34(4):1158-1163.
47.
ScullyRESchoenfeldAJJiangW, et al. Defining optimal length of opioid pain medication prescription after common surgical procedures. JAMA Surg. 2018;153(1):37-43.
48.
ShahKNRuddellJHReidDBC, et al. Opioid-limiting regulation: effect on patients undergoing knee and shoulder arthroscopy. Arthroscopy. 2020;36(3):824-831.
49.
ShanmugamVKCouchKSMcNishSAmdurRL.Relationship between opioid treatment and rate of healing in chronic wounds. Wound Repair Regen. 2017;25(1):120-130.
50.
SmithSRBidoJCollinsJE, et al. Impact of preoperative opioid use on total knee arthroplasty outcomes. J Bone Joint Surg Am. 2017;99(10):803-808.
51.
TashjianRZ.Epidemiology, natural history, and indications for treatment of rotator cuff tears. Clin Sports Med. 2012;31(4):589-604.
52.
TravenSABrintonDSimpsonKN, et al. Preoperative shoulder injections are associated with increased risk of revision rotator cuff repair. Arthroscopy. 2019;35(3):706-713.
53.
TravenSAHornRWReevesRA, et al. The 5-factor modified frailty index predicts complications, hospital admission, and mortality following arthroscopic rotator cuff repair. Arthroscopy. 2020;36(2):383-388.
VowlesKEMcEnteeMLJulnesPS, et al. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156(4):569-576.
56.
WeickJBawaHDirschlDRLuuHH.Preoperative opioid use is associated with higher readmission and revision rates in total knee and total hip arthroplasty. J Bone Joint Surg Am. 2018;100(14):1171-1176.
57.
WestermannRWAnthonyCABedardN, et al. Opioid consumption after rotator cuff repair. Arthroscopy. 2017;33(8):1467-1472.
58.
WilliamsBTRedlichNJMickschlDJGrindelSI.Influence of preoperative opioid use on postoperative outcomes and opioid use after arthroscopic rotator cuff repair. J Shoulder Elbow Surg. 2019;28(3):453-460.
59.
WilsonJMFarleyKXAizpuruM, et al. The impact of preoperative opioid use disorder on complications and costs following primary total hip and knee arthroplasty. Adv Orthop. 2019;2019:9319480.
